Cargando…

Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products

The US Family Smoking Prevention and Tobacco Control Act and WHO Framework Convention on Tobacco Control provide us with powerful tools to reduce the death and disease caused by the use of tobacco products. One tool that can contribute substantially toward this goal is the authority to establish per...

Descripción completa

Detalles Bibliográficos
Autor principal: Hatsukami, Dorothy K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632989/
https://www.ncbi.nlm.nih.gov/pubmed/23591505
http://dx.doi.org/10.1136/tobaccocontrol-2012-050785
_version_ 1782266923455610880
author Hatsukami, Dorothy K
author_facet Hatsukami, Dorothy K
author_sort Hatsukami, Dorothy K
collection PubMed
description The US Family Smoking Prevention and Tobacco Control Act and WHO Framework Convention on Tobacco Control provide us with powerful tools to reduce the death and disease caused by the use of tobacco products. One tool that can contribute substantially toward this goal is the authority to establish performance standards for tobacco products. Conjointly with reducing levels of nicotine in cigarettes, performance and quality control standards need to be established for non-combusted tobacco products. Performance standards and incentives should be provided so that tobacco companies are compelled to manufacture and market products with very low or almost non-existent toxicity (eg, nicotine-only products).
format Online
Article
Text
id pubmed-3632989
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36329892013-04-25 Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products Hatsukami, Dorothy K Tob Control Commentary The US Family Smoking Prevention and Tobacco Control Act and WHO Framework Convention on Tobacco Control provide us with powerful tools to reduce the death and disease caused by the use of tobacco products. One tool that can contribute substantially toward this goal is the authority to establish performance standards for tobacco products. Conjointly with reducing levels of nicotine in cigarettes, performance and quality control standards need to be established for non-combusted tobacco products. Performance standards and incentives should be provided so that tobacco companies are compelled to manufacture and market products with very low or almost non-existent toxicity (eg, nicotine-only products). BMJ Publishing Group 2013-05 /pmc/articles/PMC3632989/ /pubmed/23591505 http://dx.doi.org/10.1136/tobaccocontrol-2012-050785 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode
spellingShingle Commentary
Hatsukami, Dorothy K
Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products
title Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products
title_full Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products
title_fullStr Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products
title_full_unstemmed Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products
title_short Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products
title_sort ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632989/
https://www.ncbi.nlm.nih.gov/pubmed/23591505
http://dx.doi.org/10.1136/tobaccocontrol-2012-050785
work_keys_str_mv AT hatsukamidorothyk endingtobaccocausedmortalityandmorbiditythecaseforperformancestandardsfortobaccoproducts